Article History
Received: 19 January 2024
Accepted: 22 March 2024
First Online: 24 April 2024
Declarations
:
: Dr. David Bell is an editorial board member of Diabetes Therapy. Dr. Bell was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. He has no other conflicts of interest to declare. Dr. Terri Jerkins has received funding from NovoNordisk, Corcept, and Bayer Pharmaceuticals as a speaker, and she has research funding from AbbVie, Crinetics, and NovoNordisk Pharmaceuticals. Dr. Katherine Stockham as no conflicts of interest to declare.
: Written informed consent to publish was provided by the patient prior to the development and production of this paper.